Health Catalyst
HCAT
88 hedge funds and large institutions have $811M invested in Health Catalyst in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 15 closing their positions.
2,574% more call options, than puts
Call options by funds: $909K | Put options by funds: $34K
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
100% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 17
55% more capital invested
Capital invested by funds: $523M → $811M (+$288M)
53% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 15
18.54% more ownership
Funds ownership: 45.75% → 64.28% (+19%)
2% more funds holding
Funds holding: 86 → 88 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$13.2M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$9.81M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$9.61M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$7.14M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$5.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alkeon Capital Management
New York
|
-$15.9M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$14.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.75M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.79M |
HCAT Hedge Fund Activity: Q4 2019 in Review
88 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q4 2019, worth a combined $811M — up 55% from $523M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new HCAT positions and 15 closed out — a net gain of 8 holders — while 34 added to existing stakes and 17 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $13.2M. The largest seller was Alkeon Capital Management, exiting entirely with an estimated $15.9M sold.
- 88 institutional investors held Health Catalyst (HCAT) as of Q4 2019, up from 86 in Q3 2019.
- Funds reported $811M of Health Catalyst stock for Q4 2019, up 55% quarter-over-quarter.
- 23 funds opened new Health Catalyst positions in Q4 2019 and 15 closed out, a net change of +8 holders.
- The largest Health Catalyst buyer in Q4 2019 was Invesco, an estimated $13.2M added.
- The largest Health Catalyst seller in Q4 2019 was Alkeon Capital Management, an estimated $15.9M sold.
Based on aggregated 13F filings for Q4 2019.